United States· US:47682-868_545fa5b6-781d-18ae-e063-6294a90a2f0d
Medi First Triple Antibiotic
A medicinal product containing neomycin sulfate; bacitracin zinc; polymyxin b sulfate, registered in United States by Unifirst First Aid Corporation.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NEOMYCIN SULFATE; BACITRACIN ZINC; POLYMYXIN B SULFATE
- Manufacturer
- Unifirst First Aid Corporation
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1147682-868-66
- ndc1147682-868-69
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4f62b48-42aa-4fc9-8282-b29d57ceb678 GET /v1/drugs/f4f62b48-42aa-4fc9-8282-b29d57ceb678?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "3.5; 400; 5000",
"substance": "NEOMYCIN SULFATE; BACITRACIN ZINC; POLYMYXIN B SULFATE",
"productndc": "47682-868",
"dosage_form": "OINTMENT",
"dea_schedule": null,
"strength_unit": "mg/g; [USP'U]/g; [USP'U]/g",
"application_number": "M004",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about neomycin sulfate; bacitracin zinc; polymyxin b sulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.